Stocks · Health care · Services-Commercial Physical & Biological Research

MAXCYTE, INC.

MXCT Clue Score24
United States Fiscal year ends December CIK 0001287098 Results filed 14 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Douglas J Swirsky
17 Mar 2026
Chief Financial Officer
Sell
10,142
$0.82
$8.27K
Douglas J Swirsky
18 Mar 2025
Chief Financial Officer
Sell
6,939
$3.18
$22.06K
David I. Sandoval
18 Mar 2025
General Counsel
Sell
353
$3.18
$1.12K
Ali Soleymannezhad
18 Mar 2025
Chief Commercial Officer
Sell
1,211
$3.18
$3.85K
David I. Sandoval
13 Jan 2025
General Counsel
Sell
4,466
$4.54
$20.27K
Casdin Partners Master Fund, L.P.
3 Oct 2022
10% owner
Sell
735,786
$6.15
$4.53M
Casdin Partners Master Fund, L.P.
1 Jul 2022
10% owner
Sell
3,235,548
$4.30
$13.91M

What was left out

Form 4 filings counted 142
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 88
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 2,976,079
Sales filed before the plan box existed 2
History held since 3 Aug 2021